文献速递角膜与眼表疾病

治疗性组织交联剂羟甲基甘氨酸钠的抗菌研究:对感染性角膜炎治疗的启示

Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究评估羟甲基甘氨酸钠(SMG)对甲氧西林敏感金黄色葡萄球菌(MSSA)、耐甲氧西林金黄色葡萄球菌(MRSA)、铜绿假单胞菌(PA)、耐万古霉素肠球菌(VRE)和白色念珠菌(CA)的抗菌效果。结果显示SMG对MSSA、MRSA和PA呈剂量依赖性杀菌作用,对VRE和CA效果较弱,提示SMG组织交联可能用于感染性角膜炎治疗。

要点

  • SMG对MSSA、MRSA和PA呈剂量依赖性杀菌作用。
  • SMG对VRE和CA的杀菌效果较弱。
  • SMG组织交联可能用于感染性角膜炎治疗。

核心结论

  • SMG溶液对MSSA、MRSA和PA呈剂量依赖性杀菌作用,对VRE和CA效果较弱。
  • 这些研究提出SMG组织交联用于感染性角膜炎治疗的可能性。

研究设计与样本

  • 第1组实验:MSSA、MRSA和PA分别用10-40 mM SMG处理10至120分钟。
  • 第2组实验:MRSA、PA、CA和VRE用20-200 mM SMG处理30分钟,并加入牛血清白蛋白(BSA)提供蛋白性介质、加入中和缓冲液以精确控制SMG暴露时间。
  • SMG效果通过24至48小时孵育后的病原体生长情况定量。

主要发现

  • 第1组实验中,MSSA呈现时间和浓度依赖性杀菌效果。
  • 40 mM SMG处理2小时对MSSA杀菌率99.3%、对MRSA杀菌率96.0%、对PA杀菌率97.4%,处理30分钟和10分钟效果较弱。
  • 第2组实验中,200 mM SMG处理30分钟对MRSA杀菌率91%、对PA杀菌率99%、对VRE杀菌率55%。
  • SMG对CA效果较差,80 mM SMG时最大杀菌率为37%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our recent studies raise the possibility of using sodium hydroxymethylglycinate (SMG), for pharmacologic therapeutic tissue cross-linking (TXL) of the cornea. The present study was performed to evaluate the antimicrobial effects of SMG for potential use in treating infectious keratitis. METHODS: In initial (group 1) experiments, methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa (PA) were treated with SMG (10-40 mM) for 10 to 120 minutes. In group 2 experiments, MRSA, PA, Candida albicans (CA), and vancomycin-resistant Enterococcus (VRE) were treated with SMG (20-200 mM) for 30 minutes. In group 2 experiments, BSA and neutralizing buffer were added to provide a proteinaceous medium, and to ensure precise control of SMG exposure times, respectively. SMG effectiveness was quantitated based on pathogen growth following a 24- to 48-hour incubation period. RESULTS: In group 1 experiments, as expected, time- and concentration-dependent bactericidal effects were noted using MSSA. In addition, the effect of SMG (40 mM) was greatest against MSSA (99.3%), MRSA (96.0%), and PA (97.4%) following a 2-hour exposure with lesser effects following 30- and 10-minute exposures. In group 2 experiments, concentration-dependent bactericidal effects were confirmed for MRSA (91%), PA (99%), and VRE (55%) for 200-mM SMG with 30-minute treatment. SMG was not as effective against CA, with a maximum kill rate of 37% at 80 mM SMG. CONCLUSIONS: SMG solution exhibits a dose-dependent bactericidal effect on MSSA, MRSA, and PA, with milder effects on VRE and CA. These studies raise the possibility of using SMG TXL for the treatment of infectious keratitis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Rapuano PB, Scanameo AH, Amponin DE, et al. Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis. Invest Ophthalmol Vis Sci. 2018. PMID: 29346493. doi:10.1167/iovs.17-23111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。